{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:34:24Z","timestamp":1770834864702,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-025-01091-0","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:52:33Z","timestamp":1749066753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The 100th Monoclonal Antibody Product is Approved in Japan"],"prefix":"10.1208","volume":"27","author":[{"given":"Aya","family":"Hariu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Shirahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayo","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6778-7114","authenticated-orcid":false,"given":"Ryosuke","family":"Kuribayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"1091_CR1","unstructured":"PMDA. List of approved products for new drugs. \nhttps:\/\/www.pmda.go.jp\/english\/review-services\/reviews\/approved-information\/drugs\/0002.html."},{"key":"1091_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/d41573-021-00079-7","volume":"20","author":"A Mullard","year":"2021","unstructured":"Mullard A. FDA approves 100th monoclonal antibody product. Nat Rev Drug Discov. 2021;20:491\u20135. https:\/\/doi.org\/10.1038\/d41573-021-00079-7.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"1091_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/abt\/tbac021","volume":"5","author":"X Lyu","year":"2022","unstructured":"Lyu X, Zhao Q, Hui J, Wang T, Lin M, Wang K, et al. The global landscape of approved antibody therapies. Antib Ther. 2022;5(4):233\u201357. https:\/\/doi.org\/10.1093\/abt\/tbac021.","journal-title":"Antib Ther"},{"key":"1091_CR4","unstructured":"Antibody Society. Antibody therapeutics approved or in regulatory review in the EU or US. https:\/\/www.antibodysociety.org\/resources\/approved-antibodies\/ Accessed 12 April 2025."},{"key":"1091_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/clpt.2009.215","volume":"87","author":"Y Hirai","year":"2010","unstructured":"Hirai Y, Kinoshita H, Kusama M, Yasuda K, Sugiyama Y, Ono S. Delays in new drug applications in Japan and industrial R&D strategies. Clin Pharmacol Ther. 2010;87:212\u20138. https:\/\/doi.org\/10.1038\/clpt.2009.215.","journal-title":"Clin Pharmacol Ther."},{"key":"1091_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2710.2009.01099.x","volume":"35","author":"K Tsuji","year":"2010","unstructured":"Tsuji K, Tsutani K. Approval of new drugs 1999\u20132007: comparison of the US, the EU and Japan situations. J Clin Pharm Ther. 2010;35:289\u2013301. https:\/\/doi.org\/10.1111\/j.1365-2710.2009.01099.x.","journal-title":"J Clin Pharm Ther."},{"key":"1091_CR7","unstructured":"MHLW. Basic principles on Global Clinical Trials. 2007. https:\/\/www.pmda.go.jp\/files\/000153265.pdf Accessed 13 April 2025."},{"key":"1091_CR8","unstructured":"MHLW. Basic Principles on Global Clinical Trials (Reference Cases). 2012. https:\/\/www.pmda.go.jp\/files\/000157520.pdf Accessed 13 April 2025."},{"key":"1091_CR9","unstructured":"ICH E17. General principles for planning and design of multi-regional clinical trials. 2017. https:\/\/www.pmda.go.jp\/files\/000224562.pdf Accessed 13 April 2025."},{"key":"1091_CR10","unstructured":"Tanaka D. Regulatory updates in Japan. 2024. https:\/\/www.pmda.go.jp\/files\/000269411.pdf Accessed 13 April 2025."},{"key":"1091_CR11","unstructured":"The Japan News. Japanese government to lower hurdles for new drug applications; aims to improve Japan\u2019s \u2018drug loss\u2019 problem. https:\/\/japannews.yomiuri.co.jp\/society\/general-news\/20240429-183065\/ Accessed 13 April 2025."},{"key":"1091_CR12","unstructured":"MHLW. Basic principles for conducting phase 1 studies in Japanese prior to initiating multi-regional clinical trials including Japan for drugs in which early clinical development is preceding outside Japan. 2023. https:\/\/www.pmda.go.jp\/files\/000266727.pdf Accessed 13 April 2025."},{"key":"1091_CR13","unstructured":"MHLW. Q&A for basic principles for conducting phase 1 studies in Japanese prior to initiating multi-regional clinical trials including Japan for drugs in which early clinical development is preceding outside Japan. https:\/\/www.pmda.go.jp\/files\/000266728.pdf Accessed 13 April 2025."},{"key":"1091_CR14","unstructured":"MHLW. Partial Revision of \u201cDesignation of Orphan Drugs etc.\u201d 2024. https:\/\/www.pmda.go.jp\/files\/000268408.pdf Accessed 13 April 2025."},{"key":"1091_CR15","unstructured":"MHLW. Questions and answers (Q&A) for designation of orphan drugs etc. 2024. https:\/\/www.pmda.go.jp\/files\/000268407.pdf Accessed 13 April 2025."},{"key":"1091_CR16","unstructured":"MHLW. Partial revision of \u201cPlanning of the pediatric drug development program during development of drugs for adults\u201d. 2024. https:\/\/www.pmda.go.jp\/files\/000268523.pdf Accessed 13 April 2025."},{"key":"1091_CR17","unstructured":"MHLW. Q & A for \u201cPlanning of the pediatric drug development program during development of drugs for adults\u201d. 2024. https:\/\/www.pmda.go.jp\/files\/000268524.pdf Accessed 13 April 2025."},{"key":"1091_CR18","unstructured":"IQVIA. Global Trends in R&D 2025. 2025. https:\/\/www.iqvia.com\/insights\/the-iqvia-institute\/reports-and-publications\/reports\/global-trends-in-r-and-d-2025 Accessed 23 April 2025."},{"key":"1091_CR19","unstructured":"PMDA. PMDA Washington D.C. Office. 2024. https:\/\/www.pmda.go.jp\/english\/int-activities\/overseas-office\/dc\/0001.html Accessed 23 April 2025."},{"key":"1091_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-025-00049-3","author":"P Verdin","year":"2025","unstructured":"Verdin P. Top companies and drugs by sales in 2024. Nat Rev Drug Discov. 2025. https:\/\/doi.org\/10.1038\/d41573-025-00049-3.","journal-title":"Nat Rev Drug Discov"},{"key":"1091_CR21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41573-023-00709-2","volume":"22","author":"C Dumontet","year":"2023","unstructured":"Dumontet C, Reichert JM, Senter PD, Lambert JM, Beck A. Antibody-drug conjugates come of age in oncology. Nat Rev Drug Discov. 2023;22:641\u201361. https:\/\/doi.org\/10.1038\/s41573-023-00709-2.","journal-title":"Nat Rev Drug Discov"},{"key":"1091_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41573-024-00896-6","volume":"23","author":"C Klein","year":"2024","unstructured":"Klein C, Brinkmann U, Reichert JM, Kontermann RE. The present and future of bispecific antibodies for cancer therapy. Nat Rev Drug Discov. 2024;23:301\u201319. https:\/\/doi.org\/10.1038\/s41573-024-00896-6.","journal-title":"Nat Rev Drug Discov"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01091-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-025-01091-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01091-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T13:52:01Z","timestamp":1751637121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-025-01091-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1208\/s12248-025-01091-0","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All authors declare that they have no conflicts of interest that may be relevant to the contents of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The views expressed in this article are those of the authors and may not necessarily reflect the official views of the PMDA.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"105"}}